Ponatinib in patients with refractory acute myeloid leukaemia: Findings from a phase 1 study

  • Neil P. Shah
  • , Moshe Talpaz
  • , Michael W.N. Deininger
  • , Michael J. Mauro
  • , Ian W. Flinn
  • , Dale Bixby
  • , Stephanie Lustgarten
  • , Joseph M. Gozgit
  • , Tim Clackson
  • , Christopher D. Turner
  • , Frank G. Haluska
  • , Hagop Kantarjian
  • , Jorge E. Cortes

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
Pages (from-to)548-552
Number of pages5
JournalBritish Journal of Haematology
Volume162
Issue number4
DOIs
StatePublished - Aug 2013
Externally publishedYes

Keywords

  • Acute myeloid leukaemia
  • FLT3 internal tandem duplications
  • FMS-like tyrosine kinase-3
  • Ponatinib
  • Tyrosine kinase inhibitor

ASJC Scopus subject areas

  • Hematology

Cite this